Patents
Literature
Hiro is an intelligent assistant for R&D personnel, combined with Patent DNA, to facilitate innovative research.
Hiro

92 results about "Skin Lightening Agent" patented technology

Hydroquinone is a skin-bleaching agent that is used to lighten areas of darkened skin such as freckles, chloasma (also known as melasma), age spots, and acne scars.

Skin lightening compositions and methods

InactiveUS20080305059A1Effective for skin lightening/even toningCosmetic preparationsHair cosmeticsNormal skinPigments skin
Skin lightening / even toning compositions are provided for reducing skin pigmentation of normal skin and for lightening hyper-pigmented skin said compositions comprising (i) highly purified hexylresorcinol which is substantially free or resorcinol, (ii) optionally, at least one other skin lightening agent, and (iii) a dermatologically acceptable carrier.
Owner:SYTHEON

Skin lightening agents, compositions and methods

InactiveUS6852310B2Effective skin lightening propertyLess irritatingCosmetic preparationsHair cosmeticsHydrogen atomAlkoxy group
Cosmetic methods of skin lightening using coumarin derivatives of formula I as skin lightening agents alone or in combination with other skin benefit agents and together with a cosmetic vehicle: Where each or both R1 and / or R2 represents hydrogen; linear or branched C1-C18 alkyl, alkenyl, cycloalkyl, cycloalkenyl, hydroxyalkyl, hydroxyalkenyl, acyl, cycloacyl, or alkoxy groups;Each or both R3 and / or R4, which may be connected by a single or double carbon-carbon bond (shown as a dotted line), represents hydrogen; linear or branched C1-C18 alkyl, alkenyl, alkoxy, cycloalkyl, or cycloalkenyl group; andEach or both R5 and / or R6 represents a hydrogen atom, OH, C1-C4 acyl group, C1-C4 alkyl group, O—CO—R7, O—COO—R8 group, mesyl group or tosyl group, where each or both R7 and / or R8 represents hydrogen; linear or branched C1-C18 alkyl, alkenyl, hydroxyalkyl, hydroxyalkenyl, acyl, cycloacyl, or alkoxy groups.
Owner:UNILEVER HOME & PERSONAL CARE USA DIV OF CONOPCO IN C

Skin lightening agents, compositions and methods

InactiveUS7250158B1Effective skin lightening propertyLess irritatingCosmetic preparationsBiocideHydrogenHydrogen atom
Cosmetic compositions and methods, particularly for skin lightening, using compound and derivatives of general formula I and / or II as skin lightening agents alone or in combination with other skin benefit agents and together with a cosmetic vehicle:Where each R, independently, represents a hydrogen atom, C1–C4 acyl group, or C1–C4 alkyl group. Preferably, the compound is 4-hydroxyphenylpyruvate, i.e., where each R in the formula I is Hydrogen.
Owner:CONOPCO INC D B A UNILEVER

Skin lightening agents, compositions and methods

Cosmetic compositions and methods of skin lightening using compounds of formula I as skin lightening agents: Wherein X represents Carbon, Nitrogen, Sulfur or Oxygen;each A1 and / or A2 independently is =H or COR, CO2R, CONHR having the following formula A: where R=C1-C18 saturated or unsaturated, linear or branched, hydrocarbon; andeach Y1 and / or Y2 independently is C1-C18 saturated or unsaturated hydrocarbon or OZ, where Z=H or COR1, CO2R1, CONHR1 of formula B: and where R1=C1-C18 saturated or unsaturated, linear or branched, hydrocarbon.
Owner:UNILEVER HOME & PERSONAL CARE USA DIV OF CONOPCO IN C

Skin lightening agents, compositions and methods

Cosmetic compositions and methods, particularly for skin lightening, using 7-hydroxy-2-phenyl coumarin and derivatives of general formula I as skin lightening agents alone or in combination with other skin benefit agents and together with a cosmetic vehicle:Where R1 and / or R2 may be positioned at the 1-, 2-, 3-, 5-, and / or 6-positions on the phenyl ring. Each or both R1 and / or R2 represents a hydrogen atom, OH, C1–C4 acyl group, or C1–C4 alkyl group; andR represents a hydrogen atom, C1–C4 acyl group, or C1–C4 alkyl group.
Owner:CONOPCO INC D B A UNILEVER

Combined energy and topical composition application for regulating the condition of mammalian skin

Method for regulating the condition of mammalian skin comprising the steps of applying a first personal care composition to an area of skin where regulation is desired, wherein the first personal care composition comprises at least one skin care active selected from the group consisting of niacinamide, salicylic acid, peptides, N-acetyl glucosamine, panthenol, butylated hydroxytoluene, N-acyl amino acid compounds, hexamidine, green tea, ascorbyl glucoside, hexanediol, pentanediol, a skin lightening agent, a heat shock protein potentiator, and mixtures thereof, and delivering energy to the area of skin by contacting the skin with an energy delivery device for a treatment period of at least 2½ minutes, wherein the energy delivery device comprises a skin-contacting surface that is controllably heatable to a temperature of from 37° C. to 50° C.
Owner:THE PROCTER & GAMBLE COMPANY

New and improved skin treatment systems

A basic facial and body treatment cosmetic formulation is a combination of a cationic emulsifying agent, an oil soluble liquid polymer and a naturally occurring lactate buffer system. The basic formulation is a starter system that can be specialized to skin moisturizers, skin lighteners, skin pigmenting agents, sunscreens, antioxidants, line reducing products, wrinkle reducing products, anti-cellulite products, pharmaceuticals and the like.
Owner:DAMAGE CONTROL TECH

Imrpoved Skin Brightening Compositions

InactiveUS20100330007A1Enhanced ability to lighten skin colorReduce stimulationAntibacterial agentsCosmetic preparationsRetinoidIrritation
An improved cosmetic and dermatological composition and a method for treating hyperpigmented skin is disclosed. The composition demonstrates an ability to lighten mammalian skin color and is nonirritating. The composition contains (a) a retinoid loaded onto polymeric microparticles and (b) a second skin lightening agent, like kojic acid or a derivative thereof, such as kojic dipalmitate.
Owner:AMCOL INTERNATIONAL CORPORATION

Personal product compositions comprising structured benefit agent premix or delivery vehicle and providing enhanced effect of hydrophobic material separate from the structured benefit agent

The present invention comprises a structured premix or “delivery vehicle” composition designed as a carrier to enhance the benefit (e.g., via enhanced deposition or other mechanism) of a separate hydrophobic benefit agent(s) (for example, perfumes, skin lightening agents, etc.), from personal product compositions (e.g., liquid and bar cleansers, creams, emulsions, hair composition, deodorant etc.). When the structured benefit agent composition is separately prepared and combined with the personal product composition (preferably while structured, premix composition is still in molten or liquid state), the personal product composition with structured benefit agent carrier provides enhanced deposition of the structured benefit agent and enhanced effect of the separate hydrophobic benefit agent(s) in or on the carrier or in the presence of structured benefit agent carrier.
Owner:UNILEVER HOME & PERSONAL CARE USA DIV OF CONOPCO IN C

Boron nitride-containing silicone gel composition

A stable silicone oil composition is provided which comprises:a) at least one silicone gel;b) at least one boron nitride powder (a);c) a static charge-dissipating amount of at least one silicone oil; and,d) optionally, at least one component selected from the group consisting of other silicone, surfactant, emulsifier, solvent, emollient, moisturizer, humectant, pigment, colorant, fragrance, preservative, antioxidant, biocide, biostat, antiperspirant, exfoliant, hormone, enzyme, medicinal, vitamin substance, hydroxy acid, retinol, retinol derivative, niacinamide, skin lightening agent, salt, electrolyte, alcohol, polyol, ester, ultraviolet radiation scattering and / or absorbing agent, botanical extract, peptide, protein, organic oil, gum, saccharide, oligosaccharide, polysaccharide, derivative, wax, film former, thickening agent, particulate filler, plasticizer, humectant, occlusive, sensory enhancer, resin and optically active particle.
Owner:MOMENTIVE PERFORMANCE MATERIALS INC

Composition containing leukocyte extract for the whitening or lightening of skin

InactiveUS7226583B2Inhibits the formation of melaninIncrease ratingsCosmetic preparationsBiocideKojic acidMagnesium phosphate
Cosmetic compositions intended for topical application to the skin for lightening and / or brightening the skin are provided. The subject compositions are characterized by the presence of leukocyte extract in combination with one or more secondary skin whitening or brightening agents. A preferred group of such agents includes bearberry, arbutin, rutin, ascorbyl glucoside, ascorbyl magnesium phosphate, hydroquinone, kojic acid or combinations thereof. Another group of preferred agents includes extracts of mulberry, lemon, orange, licorice, cucumber, cinnamon, cherry (fermentate), rosemary and / or derivatives thereof. It has been found that the combination of leukocyte extract with such agents possesses enhanced efficacy over similar preparations that do not contain leukocyte extract.
Owner:HAIR SYST

Methods and compositions for preventing and treating hyperpigmentation of skin

Disclosed are methods for treating hyperpigmentation of skin employing topical application of compositions which comprise at least one peptide manganese complex. Also disclosed are methods wherein the composition further comprises retinol, at least one retinol derivative, or a mixture thereof and methods wherein the composition further comprises active agents selected from active drug substances, emollients, sunscreen agents, skin lightening agents, skin protectants, skin conditioning agents, humectants, and mixtures thereof.
Owner:PROCYTE

Personal care and cosmetic composition containing tetrapeptides with the motifs gx1x2g, px1x2p, or px1x2k

The present invention relates to topical personal care and skin care compositions comprising: a) a safe and effective amount of a tetrapeptide selected from the group of tetrapeptides with the motif GX1X2G, PX1X2P, or PX1X2K, derivatives thereof, and mixtures thereof; b) a safe and effective amount of at least one additional active ingredient selected from the group consisting of hydroxy acids, radical scavengers, UV absorbers, vitamins, anti-aging actives, barrier lipids, desquamatory actives, retinoids, anti-acne actives, tanning actives, anti-cellulite actives, anti-inflammatory actives, antimicrobial actives, antifungal actives, skin lightening agents, skin energizing agents, skin healing agents, moisturizing actives, and mixtures thereof; and c) a dermatologically acceptable carrier.
Owner:EVONIK GOLDSCHMIDT GMBH

Resorcinol composition

InactiveUS20020155075A1Prevent repigmentationEnhance ability to reduce skin melanin skinCosmetic preparationsHair cosmeticsMedicineCyclohexanol
The present invention relates to the use of a resorcinol derivative, i.e., 4-(2,4-dihydroxyphenyl)cyclohexanol, or a pharmaceutically acceptable salt thereof, as a skin lightening agent.
Owner:PFIZER INC

Skin lightening agents, compositions and methods

Cosmetic compositions and methods, particularly for skin lightening, using N-acylbenzothiazolone compound and derivatives of general formula I as skin lightening agents alone or in combination with other skin benefit agents and together with a cosmetic vehicle:Where R represents a hydrogen atom, C1-C4 acyl group, or C1-C4 alkyl group. Preferably, the compound is 3-propionylbenzothiazol-2-one, i.e. where R in the formula I is C1 alkyl group.
Owner:CONOPCO INC D B A UNILEVER

Malassezin and analogs thereof as skin brightening agents

ActiveUS20170260133A1Cosmetic preparationsOrganic chemistryReceptorHyperpigmentation disorder
The present invention relates to compounds, compositions, and methods for brightening skin. The compounds, compositions, and methods of the present invention generally involve compounds produced by a Malassezia yeast, and chemical analogs thereof. In addition to skin brightening applications, the compounds, compositions, and methods of the present invention may be used to modulate melanocyte activity, induce melanocyte apoptosis, agonize an arylhydrocarbon receptor (AhR), improve hyperpigmentation caused by a hyperpigmentation disorder, and modulate melanin production, melanosome biogenesis, and melanosome transfer.
Owner:VERSICOLOR TECH LLC

System for Identifying Connections Between Perturbagens and Genes Associated with a Skin Hyperpigmentation Condition

A system for identifying connections between perturbagens and genes associated with a skin hyperpigmentation condition. The system includes a computer readable medium having a plurality of instances stored thereon, and a skin hyperpigmentation-relevant gene expression signature. Each instance includes an instance list of rank-ordered identifiers of differentially expressed genes, and the hyperpigmentation-relevant gene expression signature includes a gene expression signature list of identifiers representing differentially expressed genes associated with a hyperpigmentation condition or differentially expressed genes associated with a benchmark skin-lightening agent. The system also includes a programmable computer with computer-readable instructions that allow the computer to accessing the instances and a hyperpigmentation-relevant gene expression signature stored on the computer readable medium, comparing the hyperpigmentation-relevant gene expression signature to the plurality of the instances, and / or assigning a connectivity score to each of the plurality of instances.
Owner:THE PROCTER & GAMBLE COMPANY

Resorcinol composition

The present invention relates to the use of a resorcinol derivative, i.e., 4-(2,4-dihydroxyphenyl)cyclohexanol, or a pharmaceutically acceptable salt thereof, as a skin lightening agent.
Owner:PFIZER INC

Dopa Oxidase Inhibitor, Skin-Lightening Agent and External Preparation for Skin

InactiveUS20110117038A1Inhibiting oxidase activityInhibit melanin productionOrganic active ingredientsBiocideSenecioMedicine
A dopa oxidase inhibitor, a skin-lightening agent and an external preparation for skin; comprising an extract of at least one plant selected from the group consisting of Melia toosendan Sieb. et Zucc., Amomum tsao-ka Crevost et Lemaire. Senecio gracilis and Veratrum nigrum L., or a compound represented by the following Formula (1), as an active ingredient:wherein R represents an acyl group having 1 to 5 carbon atom(s).
Owner:KAO CORP

Methods and compositions for preventing and treating aging or photodamaged skin

InactiveUS20060246029A1Diminishing sign of aging and photodamageIncreased proliferationCosmetic preparationsBiocideSunscreen agentsVitamin A Retinol
Disclosed are methods for treating aging and photodamaged skin employing topical application of compositions which comprise at least one peptide manganese complex. Also disclosed are methods wherein the composition further comprises retinol, at least one retinol derivative, or a mixture thereof and methods wherein the composition further comprises active agents selected from active drug substances, emollients, sunscreen agents, skin lightening agents, skin protectants, skin conditioning agents, humectants, and mixtures thereof.
Owner:PROCYTE

Washable skin care fabric product

The invention discloses a washable skin care fabric product comprising a fabric base material, and a skin care layer detachably arranged on the fabric base material, wherein the skin care layer comprises microcapsules, and the microcapsules contain at least two active ingredients for improving a skin condition of a user. The active ingredients are selected from the groups formed by the following components: a skin moisturizer, a skin whitening agent, a skin anti-aging agent, an aromatic agent and combinations thereof; the skin care layer can be placed to be in direct contact with the user skin.
Owner:程讌雯

Terrein compound having melanin biosynthesis inhibitors and its preparation

The present invention relates to a melanin biosynthesis inhibitor containing terrein compound as an effective ingredient. The terrein compound can be easily separated from Penicillium sp KCTC 26245, a fungal strain inhabited in domestic soil. It does not directly inhibit tyrosinase but inhibits the expression of MITF (microphthalmia-associated transcription factor) by activating ERK (extracellular signal-regulated kinase) in melanin chromatocytes to give whitening effect. So, the melanin biosynthesis inhibiting effect of the compound is much greater than that of any other conventional inhibitors, and further the effect can be raised when the compound is used together with other inhibitors, owing to their different mechanisms. Thus, the compound of the present invention can be effectively used as a skin trouble treating agent, a skin whitening agent and a browning inhibitor.
Owner:KOREA RES INST OF BIOSCI & BIOTECH +1
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products